Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Todd Neale

October 17, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Features

As US Abortion Protections Are Lost, Cardiologists Brace for Impact

Todd Neale

June 24, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

News Features

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

Yael L. Maxwell

April 21, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Features

Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope

Caitlin E. Cox

June 02, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Features

TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind

Todd Neale

January 02, 2020

Advertisement

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Valvular Heart Disease Has a Diversity Problem

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

As US Abortion Protections Are Lost, Cardiologists Brace for Impact

Minorities, Poorer Patients Missing Out on Structural Heart Care

As TAVI Turns 20, How Has the Heart Team Evolved?

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

Roughly 80% of ESC Guideline Writers Have Financial COIs

Funding the Future: How Industry Support for CV Trials Could Evolve

Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content